Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Disturbed metabolic adaptation drives natural killer cell dysfunction in association with nosocomial infection during human sepsis.

EBioMedicine·2026

Same author

Improving bedside airway tests accuracy for predicting difficult laryngoscopy using ultrasound-measured skin-to-epiglottis distance.

Journal of anesthesia, analgesia and critical care·2026

Same author

Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts.

Science translational medicine·2026

Same author

Norepinephrine in Major Abdominal Surgery: Comment.

Anesthesiology·2026

Same author

Prevalence and risk factors associated with asymptomatic bacteriuria in diabetic postmenopausal women in Tripoli, Libya.

BMC infectious diseases·2026

Same author

APNEIC-M score: a simplified screening tool for difficult airway in patients with obesity.

Journal of anesthesia·2026

Search research articles

相关实验视频

Updated: Jun 16, 2026

Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells

Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells

Published on: February 3, 2011

在AML中采用NK细胞疗法:进展和挑战

Mona Rady^1,2, Maha Mostafa³, Gabriel Dida^4,5

¹Microbiology, Immunology and Biotechnology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo (GUC), New Cairo, Egypt. mona.rady@guc.edu.eg.

Clinical and experimental medicine

|January 17, 2025

概括

自然杀手 (NK) 细胞采用细胞疗法 (ACT) 对急性髓性白血病 (AML) 显示出前景,为化疗提供了替代方案. 虽然通常是安全的,但诸如有限的持久性和患者反应的变化等挑战需要进一步研究以获得最佳的疗效.

关键词:

急性髓性白血病 (AML) 是一种疾病.收养细胞疗法 (ACT) 是一种细胞疗法.移植与宿主的疾病 (GVHD)移植与白血病对比 (GVL)血造干细胞移植 (HSCT) 的方法在 NK 细胞中,NK 细胞是 NK 细胞.

更多相关视频

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

相关实验视频

Last Updated: Jun 16, 2026

Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells

Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells

Published on: February 3, 2011

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

科学领域:

免疫学和血液学
细胞疗法细胞疗法

背景情况:

使用自然杀手细胞 (NK) 的采用细胞疗法 (ACT) 是急性髓性白血病 (AML) 的发展策略.
NK细胞ACT的目标是克服化疗耐药性和高AML复发率.
研究了各种NK细胞来源,包括细胞系,CAR-NK细胞以及来自外周血液和带血的细胞.

研究的目的:

综合分析过去15年NK细胞为AML的ACT的临床结果和毒性概况.
评估NK细胞在AML治疗中的有效性,安全性和适用性.
确定针对AML的NK细胞疗法的持续挑战和改进领域.

主要方法:

对临床试验,临床研究和关于AMLNK细胞ACT的病例报告的审查.
分析的重点是治疗疗效,包括抗白血病活性和缓解率.
对安全性概况的评估,特别注意细胞因子释放综合征 (CRS) 和移植与宿主疾病 (GVHD) 的发生率.

主要成果:

在一些AML患者中,NK细胞疗法显示出不同的疗效,从短暂的效果到持续的缓解.
观察到普遍有利的安全结果,严重不良事件的发病率较低,如CRS和GVHD.
确定的主要挑战包括有限的NK细胞持久性,疾病复发和不一致的患者反应.

结论:

基于NK细胞的采用细胞疗法具有治疗AML的巨大潜力.
进一步的研究至关重要,以解决技术和生物障碍,以提高有效性和安全性.
优化NK细胞的持久性和反应异质性是未来发展的关键领域.